Day: July 6, 2021

Trondheim, 6 July 2021: NORBIT today announces that NORBIT ITS has received an order from Fremtind Service for delivery of On-Board Units (OBUs) for electronic toll collection in the Norwegian market. The value of the order is approximately NOK 27 million and it is scheduled for delivery over the next 24 months. “This is an important first step in the strategic cooperation with Fremtind Service, which is Norway’s largest OBU issuer and a leading player in the mobility market. We look forward to continuing the collaboration and developing innovative solutions together”, says Per Jørgen Weisethaunet, CEO of NORBIT. For further queries, please contact:Per Jørgen Weisethaunet, CEO, +47 959 62 915 Per Kristian Reppe, CFO, +47 900 33 203 About NORBIT ASANORBIT is a global provider of tailored technology to carefully selected niches. The company’s...

Press ReleaseNicox: Half-year liquidity contract statement with Kepler CheuvreuxJuly 6, 2021 – release at 7:30 am CET Sophia Antipolis, France Under the liquidity contract entered into between NICOX and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2021: –        218,919 shares–        € 128,032.29 –        Number of executions on buy side on semester: 1,594 –        Number of executions on sell side on semester: 1,298 –        Traded volume on buy side on semester: 978,682 shares for € 4,245,529.01 –        Traded volume on sell side on semester: 906,908 shares for € 3,977,929.37 As a reminder : •        the following resources appeared on the last half year statement on 31 December 2020 on the liquidity account: –        147,145 shares–        €...

Investigator-sponsored FORCE trial did not meet primary endpoints Company will stop exploring avdoralimab in COVID-19 Investigator-sponsored avdoralimab clinical trial in inflammation will continue MARSEILLE, France, July 06, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that FORCE (FOR COVID-19 Elimination), the investigator-sponsored, Phase 2 clinical trial evaluating the safety and efficacy of its anti-C5aR1 antibody, avdoralimab, in COVID-19 patients with severe pneumonia, did not meet its primary endpoints in all three cohorts of the trial. The FORCE trial was initiated based on pre-clinical data showing that patients who progress towards severe COVID-19 disease exhibit an activation of the C5a/C5aR1 pathway. These translational...

Marseille, France, July 06, 2021 (GLOBE NEWSWIRE) — Investigator-sponsored FORCE trial did not meet primary endpoints Company will stop exploring avdoralimab in COVID-19 Investigator-sponsored avdoralimab clinical trial in inflammation will continue Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that FORCE (FOR COVID-19 Elimination), the investigator-sponsored, Phase 2 clinical trial evaluating the safety and efficacy of its anti-C5aR1 antibody, avdoralimab, in COVID-19 patients with severe pneumonia, did not meet its primary endpoints in all three cohorts of the trial. The FORCE trial was initiated based on pre-clinical data showing that patients who progress towards severe COVID-19 disease exhibit an activation of the C5a/C5aR1 pathway. These translational...

Kinnevik AB (publ) (“Kinnevik”) today announced that it has invested USD 22m in Pleo’s USD 150m funding round, participating above its pro rata share. The funds raised will be used to support the company’s growing 17,000+ customer base, and the development of new spend management features on its platform. Andreas Bernström, Senior Investment Director at Kinnevik, commented: “Kinnevik partnered with Pleo back in 2018. Already in those very early days we saw immense potential in the business concept and Pleo’s product execution, as well as in the founding team led by Jeppe Rindom and Niccolo Perra, both serial fintech entrepreneurs with great success and expertise behind them. We are proud to continue to support a company we believe is emerging as the category winner in its field, helping both growing and established businesses...

OSLO, Norway (6 July 2021) – TGS, a global provider of energy data and intelligence, in partnership with PGS, today announced Lewis Hills 3D multi-client phase 2 offshore East Canada. Phase 2 includes the acquisition of 947 square kilometers of additional 3D data, tying into the existing project’s 2,811 square kilometers to create one contiguous dataset. The Lewis Hill 3D volume is positioned in the highly prospective Orphan Basin, with recent discoveries in the Flemish Pass and connecting further south to the productive Jeanne D’Arc Basin. An expansive well log library is also available in the region, along with advanced multi-client interpretation products that will improve play, trend and prospect delineation. David Hajovsky, EVP of Western Hemisphere at TGS, commented, “The TGS and PGS joint venture continues to consistently...

High Grade Copper – Tin – Silver Assays From UD_21-001 New Zone of Copper Mineralisation Containing Native Copper in UD_21-007 (assays for holes 2-7 pending) VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V / AIM: CUSN) (“Cornish Metals” or the “Company”) is pleased to report the first batch of results from its current diamond drilling programme at the United Downs copper – tin project, Cornwall UK. This drill programme is designed to follow up on the discovery of high-grade copper – tin mineralisation in a structure named “Lithium Lode”, announced April 6, 2020 (14.7m grading 8.5% copper and 1.2% tin). HIGHLIGHTSDrill hole UD21_001, drilled to a total depth of 260.24m, intersected two zones of high-grade mineralisation, one with tin mineralisation, and the second with tin,...

DENVER, CO, July 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – CBD Global Sciences Inc. (CSE: CBDN) (the “Corporation“) further to its press releases dated May 14, 2021, May 28, 2021, and June 15, 2021, provides this fourth bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default announcement of April 14, 2021 (the “Default Notice”), the Corporation announced the delay in the filing of its audited annual financial statements for the year ended December 31, 2020 (the “Annual Financial Statements”) and related management’s discussion and analysis and CEO and CFO certifications (collectively, the “Annual Filings”) by the prescribed filing deadline. As previously announced in the Corporation’s press...